HHS AI Use Case Inventory 2024
The Office of the Assistant Secretary for Technology Policy’s (ASTP) Office of the Chief Artificial Intelligence Officer (OCAIO) is responsible for leading the annual HHS AI use case inventory.
This artificial intelligence (AI) use case publication requirement was first initiated by President Trump through Executive Order 13960 “Promoting the Use of Trustworthy Artificial Intelligence in the Federal Government” and further enhanced by President Biden’s Executive Order 14110 "Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence.” The Office of Management and Budget (OMB) Memoranda M-24-10 “Advancing Governance, Innovation, and Risk Management for Agency Use of Artificial Intelligence” establishes requirements and guidance for AI governance, innovation, and risk management.
Questions can be directed to HHS.CAIO@hhs.gov.
| Use Case Name | Stage of System Dev Life Cycle | Op Div/Staff Div |
|---|---|---|
| Analytics-Driven Supplement Evaluation (ASE) | Acquisition and/or Development | FDA |
| CLAT (Computerized Labeling Assessment Tool) | Acquisition and/or Development | FDA |
| Empirical evaluation of EHR-based signal detection approaches | Acquisition and/or Development | FDA |
| Scalable automated NLP-assisted chart abstraction and feature extraction tool | Acquisition and/or Development | FDA |
| Development of automation tools and data warehouse to facilitate BE assessments | Acquisition and/or Development | FDA |
| Four Part Harmony Identification | Acquisition and/or Development | FDA |
| Information Visualization Platform (InfoViP) to Support Analysis of adverse event reports | Acquisition and/or Development | FDA |
| LLM-Assisted VAERS Analyses | Acquisition and/or Development | FDA |
Quick Link 6